Chemed Corporation (NYSE:CHE) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Chemed Corporation (NYSE:CHE) have been assigned a consensus rating of “Hold” from the six analysts that are presently covering the stock, MarketBeat.com reports. Four equities research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $501.50.

Several equities analysts have recently weighed in on the company. Weiss Ratings upgraded Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Jefferies Financial Group lowered Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer lowered their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Finally, Royal Bank Of Canada boosted their price target on Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a research report on Monday, April 27th.

Insiders Place Their Bets

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Friday, May 1st. The stock was sold at an average price of $421.13, for a total value of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This represents a 2.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 3.33% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CHE. Northwestern Mutual Wealth Management Co. grew its holdings in Chemed by 2,444,879.3% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 5,550,103 shares of the company’s stock valued at $2,374,667,000 after buying an additional 5,549,876 shares in the last quarter. JPMorgan Chase & Co. boosted its stake in Chemed by 122.7% in the third quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock valued at $223,856,000 after buying an additional 275,423 shares in the last quarter. Norges Bank acquired a new stake in Chemed in the fourth quarter valued at about $76,067,000. AQR Capital Management LLC boosted its stake in Chemed by 89.2% in the fourth quarter. AQR Capital Management LLC now owns 325,579 shares of the company’s stock valued at $139,302,000 after buying an additional 153,469 shares in the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Chemed by 1,260.2% during the fourth quarter. Victory Capital Management Inc. now owns 117,685 shares of the company’s stock valued at $50,353,000 after purchasing an additional 109,033 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Stock Performance

Shares of NYSE:CHE opened at $434.43 on Friday. Chemed has a twelve month low of $365.20 and a twelve month high of $583.96. The firm has a market cap of $5.76 billion, a PE ratio of 23.67, a price-to-earnings-growth ratio of 1.60 and a beta of 0.54. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The business has a fifty day moving average of $396.73 and a 200-day moving average of $425.22.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Thursday, April 23rd. The company reported $5.65 EPS for the quarter, topping analysts’ consensus estimates of $5.30 by $0.35. The firm had revenue of $657.51 million during the quarter, compared to analyst estimates of $659.22 million. Chemed had a return on equity of 27.18% and a net margin of 10.23%.The company’s revenue was up 1.6% on a year-over-year basis. During the same period last year, the company earned $5.63 earnings per share. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, equities research analysts predict that Chemed will post 22.3 EPS for the current fiscal year.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.